Financials
- Market Capitalization 750.73 M
- Employee 92
- Founded 2011
- CEO N/A
- Website www.annexonbio.com
- Headquarter Delaware, United States
- FIGI BBG007QVDFG2
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3.75
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2567 | GYRE Gyre Therapeutics, Inc. - Common Stock | 6.87 USD | -2.41% | -7.41% | +0.73% | -16.83% | 766.07 M USD | ||
| 2573 | DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 11.80 USD | -9.30% | -23.23% | +76.12% | +32.88% | 759.22 M USD | ||
| 2587 | CADL Candel Therapeutics, Inc. - Common Stock | 9.78 USD | -1.61% | -5.23% | -6.05% | +54.02% | 748.35 M USD | ||
| 2588 | VSTM Verastem, Inc. - Common Stock | 8.25 USD | -1.55% | +2.10% | +12.09% | -9.64% | 747.15 M USD |